ANKENY, Iowa--(BUSINESS WIRE)--Advanced Analytical Technologies, Inc. (AATI) received an R&D 100 Award from R&D Magazine for the FEMTO Pulse Automated Pulsed-Field CE Instrument. As the only automated pulsed-field capillary electrophoresis system on the market, the FEMTO Pulse won the award for its ability to separate and analyze large nucleic acid fragments—up to 165,000 base pairs—with high efficiency and sensitivity. The R&D 100 Awards recognize the 100 most technologically significant products introduced into the marketplace over the past year. Commonly known as the “Oscars of Invention,” the awards have recognized pioneering technology for more than 50 years.
Successful next-generation sequencing (NGS) is reliant upon the construction of quality NGS libraries. Synthesis of these libraries, from short-read sequencing to the latest long-read sequencing applications, depends on several critical quality control (QC) checkpoints. While sequencing technology has advanced, QC methods have stagnated, limiting their application in new NGS technologies. The FEMTO Pulse fills a niche in NGS workflows, capable of quantifying and qualifying challenging samples, from initial QC steps to final library validation.
“NGS systems are now starting to analyze fragments over 50,000 base pairs, and most labs tell me they have little starting material for preparing a library and need to be able to assess its size. These are precious samples,” said Steve Siembieda, AATI’s Vice President of Commercialization.
With sequencing moving to larger and larger fragments, AATI saw a need for a completely new analytical instrument design. The result is the FEMTO Pulse, the first device of its kind to feature a parallel capillary electrophoresis platform with a pulsed-field power supply and enhanced optical sensors.
These features allow for the following benefits as compared to methods such as agarose based pulsed-field gel electrophoresis:
- Run times of about one hour, versus 14-36 hours
- Measuring samples with concentrations as low as 5 fg/µL
- Using less sample for analysis
- Accurately sizing fragments as large as 165,000 base pairs
These improvements enable the FEMTO Pulse to push the boundaries of nucleic acid detection and fragment sizing, impacting applications such as: single-cell nucleic acid analysis, PCR-free preparation of NGS library preparation, bacterial artificial chromosome (BAC) clone sizing and exosome analysis. In addition, the instrument can perform standard analyses.
For more information, visit https://www.aati-us.com/instruments/femto-pulse/.
About Advanced Analytical Technologies, Inc.
AATI develops, manufactures and markets high-throughput, fully-automated nucleic acid analysis systems. The company's products have both commercial and research applications and are designed to improve processes within the molecular diagnostics, pharmaceutical, life science, agricultural and biofuels industries. The company's product portfolio includes instruments for the parallel analysis of biomolecules, DNA, RNA, genomic DNA, double-stranded DNA and oligonucleotides using capillary electrophoresis with fluorescence detection or UV absorbance.